CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Elbit Imaging Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Elbit Imaging Ltd.
3 Shimson st. Olympia A Tower
Mailbox:2647
Phone: +972 36086000p:+972 36086000 Petah Tikva, 4912502  Israel Ticker: EMITFEMITF

On 1/1/2014, the Tel-Aviv Jaffa District Court approved the Company's adjusted plan of arrangement for a restructuring of the Company's unsecured financial debt. On 2/20/2014, the Company announced the closing of the Arrangement (debt restructuring). As part of the Arrangement, 509,713,459 ordinary shares were issued to the Company’s unsecured financial creditors, out of which 9,090,122 ordinary shares were issued at the Closing and deposited in trust for the benefit of Bank Leumi Le Israel B.M., due to the ongoing dispute between the Company and Bank Leumi regarding the validity of certain pledges registered in Bank Leumi’s favor.
This company is no longer actively traded on any major stock exchange.

Business Summary
Elbit Imaging Ltd. engages, directly and through its investee companies, in the fields of commercial centers, hotels, medical industries and devices, and plots in India. The Company's segments include Commercial centers, Hotel, Medical Industries and devices, and Plots in India. Commercial centers segment include initiation, construction and sale of commercial centers and other mixed-use real property projects, principally in the retail sector. Hotel segment is engaged in the operation and management of hotels. Medical Industries and devices segment includes research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. Plots in India segment includes plots designated for sale, initially designated to residential projects.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201812/31/2017YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board RonHadassi 52
Chief Financial Officer YaelNaftali 38 5/1/2016 1/1/2010
Vice President, General Counsel ZviMaayan 10/1/2008 10/1/2008
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Plaza Centers N.V. Pietersbergweg 283 AMSTERDAM Netherlands
Plaza Centers NV Prins Hendrikkade 48-S AMSTERDAM Netherlands
Bucuresti Turism SA Calea Victoriei 63-81 S1 Bucuresti Romania
Elbit Medical Technologies Ltd 24 Hanagar, 22 Doar Amis Ramataim HOD HASHARON Israel

Business Names
Business Name
Bea Hotels N.V.
Bucuresti Turism SA
Elbit Medical Technologies
7 additional Business Names available in full report.

General Information
Number of Employees: 655 (As of 12/31/2014)
Outstanding Shares: 9,190,808 (As of 6/30/2018)
Shareholders: 518
Stock Exchange: NASD
Fax Number: +972 36086050


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023